Everfront Biotech Co., Ltd.

This study is testing whether adding a new implant called Cerebraca Wafer to standard chemotherapy helps people with recurrent glioblastoma, a serious brain cancer, live longer. The trial will compare two groups: one receiving the wafer implant plus chemotherapy after surgery, an…